Φορτώνει......
Methylene Blue for Vasoplegic Syndrome after Cardiac Surgery: Early Administration Improves Survival
BACKGROUND: Vasoplegic syndrome, defined by hypotension despite normal or increased cardiac output, is associated with high mortality after cardiopulmonary bypass. Methylene blue (MB) is reported to ameliorate vasoplegic syndrome through the nitric oxide pathway. We hypothesized that early administr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Thorac Surg |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5523819/ https://ncbi.nlm.nih.gov/pubmed/28551045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.02.057 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|